Author

K. Riecken

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. Fehse· 2 shared A. Arner· 1 shared A. Badbaran· 1 shared A. Fathi· 1 shared C. Bokemeyer· 1 shared C. D. Baldus· 1 shared C. Dahlke· 1 shared C. Mess· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

B. Fehse

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

TAM receptors control actomyosin dynamics in osteoclasts via RHOA-COFILIN-MYOSIN II signaling

J. Engelmann, J. Zarrer, M. J. Schmerder, C. Mess, D. Ragipoglu, K. Riecken, T. Burstyn-Cohen, E. Alberto, S. Ghosh, C. V. Rothlin, K. Pantel, C. Bokemeyer, E. Hesse, H. Taipaleenmaeki, S. Loges, I. Ben-Batalla

This paper identifies TAM receptors MERTK and TYRO3 in osteoclasts regulating bone homeostasis through RHOA-COFILIN-MYOSIN II signaling, with MERTK promoting osteoclast formation and TYRO3 inhibiting it.

bioRxiv · Apr 12, 2024 · PreprintCell Biology

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues

A. Badbaran, R. Mailer, C. Dahlke, J. Woens, A. Fathi, S. C. Mellinghoff, T. Renne, M. M. Addo, K. Riecken, B. Fehse

The paper develops a highly sensitive digital PCR method to quantify ChAdOx1 nCoV-19 vector copies in blood and tissues to study vaccine-induced immune thrombotic thrombocytopenia mechanisms.

bioRxiv · May 28, 2021Microbiology

In vivo inducible reverse genetics in patients' tumors to identify individual therapeutic targets

M. Carlet, K. Voelse, J. Vergalli, M. Becker, T. Herold, A. Arner, W.-H. Liu, V. Dill, B. Fehse, C. D. Baldus, L. Bastian, L. Lenk, D. M. Schewe, J. W. Bagnoli, P. J. Jost, , I. Jeremias

The paper develops an in vivo inducible RNAi system in patient-derived xenograft models to identify therapeutic targets in acute leukemias.

bioRxiv · May 2, 2020Cancer Biology